Health
Novo forecasts flat 2026 sales as finance chief departs
For most biopharmas, guiding to flat growth for the year would be a disappointment. For Novo, it’s an upgrade. The drugmaker said Wednesday that its 2026 sales would be between 2% ...
- Published
- (11 h ago)
- Outlet
- Endpoints News
- Section
- Health
- Length here
- Headline and 32-word snippet. The full article is at the source.
More from Endpoints News and around the same time
Kamau shares first data from revamped sickle cell gene editing therapyKamau Therapeutics, which has stayed relatively quiet since its 2023 emergence, is sharing clinical data from its revamped sickle cell gene editing program for the first time. The startup is giving a ...Novo’s race to catch Eli Lilly may already be lostA year ago, the rivalry between Eli Lilly and Novo was the fiercest in the industry. Now, it looks increasingly one-sided. The best evidence might be investors' reactions to each company's third-quarter results. Both stocks ...Sanofi ends development of Nurix's STAT6 degraderSanofi is dropping an experimental drug targeting a pathway that many analysts see as a potential pillar of the next generation of immunology medicine. The company will no longer pursue the program known as SAR448272 ...CVS to break up, splitting pharmacy business from insuranceCVS Health is splitting into two publicly traded companies as the healthcare giant fights rising costs, retail competition, regulatory scrutiny and other pressures. The first company, to be named CVS Health, will host its…China climbed biotech's worry list, while Big Pharma kept shoppingIn the months leading up to the Treasury Department's release of draft rules that would limit US investment in Chinese biopharma, the industry's view of China was already in a downward sentiment ...First wave of #ASH26 abstracts is here, with data from J&J, Servier and AstraZenecaThe American Society of Hematology's annual meeting is just a little over a month away. This year's edition will be in New Orleans, LA, and Endpoints News will be covering the meeting in person. For ...This page holds the headline and a short snippet as published by Endpoints News, whose feed they came from. The story itself, the photography and the rights stay with them, and the button above goes straight to their site. We keep this page so the headline has a stable address and a record of when it ran.
